CD8A and neoplasm: Archaeosomes can also break tolerance to self-antigens [15], and since they themselves are non-immunogenic they are also highly suitable for homologous prime-boost vaccinations, generating high levels (~45%) of tumor-protective antigen-specific CD8+ T cells [16].